Shire nabbed FDA approval for its new long-acting ADHD drug, becoming the second drugmaker in two days to win a nod in that field. Shire’s drug, Mydayis, has been a long time coming. Previously known ...
After six months of relentless pursuit, Shire SHPG finally announced that it will acquire Baxalta, Inc. BXLT for $32 billion. The boards of directors of both companies have agreed to the merger. We ...
The rumors that Teva might attempt to buy Shire are puzzling because such an acquisition would present a huge internal conflict to the combined company: What to do with Shire's Vyvanse and Adderall XR ...
On paper, a cozy little game set in the Shire sounds like a slam dunk. The Shire is canonically a beautiful, peaceful, inviting little place, and a game that lets you customize your own personal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results